Response Genetics Signs on Two Blue Cross Blue Shield Plans | GenomeWeb

NEW YORK (GenomeWeb News) – Response Genetics announced today contracts with Blue Cross and Blue Shield of Minnesota and Blue Cross and Blue Shield of Nebraska.

The Los Angeles-based molecular diagnostic company is now in-network with eight Blue Cross Blue Shield plans. Today's announcement follows agreements inked between Response Genetics and four payors last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.